Sherif Emil’s Post

I am proud to share that as a member of the APSA Outcomes and Evidence-based Practice Committee, we have published a significant systematic review and evidence-based guideline in the Journal of Pediatric Surgery! Title: Classification and Surgical Management of Anorectal Malformations: A Systematic Review and Evidence-based Guideline from the APSA Outcomes and Evidence-based Practice Committee 🔍 Highlights: • Treatment of neonates with anorectal malformations (ARMs) is challenging due to variability in definitions, surgical approaches, and outcomes. • Our review summarizes existing evidence, identifies treatment controversies, and provides guidelines for perioperative care. • We reviewed 10,843 publications, with 90 included in our final recommendations. • Both loop and divided colostomies are viable options, though loop colostomies have higher prolapse rates. • No significant differences in outcomes between early and late repair groups. • Clear and uniform definitions are essential for future comparisons and recommendations. 📈 Conclusion: Evidence-based best practices for ARMs are still lacking in many areas. Multi-institutional registries and further prospective studies are crucial to improve care and develop consensus guidelines for this complex patient population. For more details, check out the full article: https://lnkd.in/g4i9iiVy #PediatricSurgery #ARMs #SystematicReview #EvidenceBasedPractice #APSA #SurgicalManagement #AnorectalMalformations #MedicalResearch #HealthcareInnovation

Charting the course for pediatric heart surgery recovery. Diaphragmatic paralysis insights for better outcomes. https://bit.ly/47mMv3W #PediatricCardiology #HeartSurgery #MedicalResearch #CongenitalHeartDisease #HealthManagement

I'm proud to share our latest systematic review published in the Journal of Pediatric Surgery on the management and outcomes of pediatric lymphatic malformations (LMs)! Title: Management and Outcomes of Pediatric Lymphatic Malformations: A Systematic Review From the APSA Outcomes and Evidence-Based Practice Committee 🔍 Highlights: • This comprehensive review addresses the significant variation in management strategies for lymphatic malformations (LMs) in children. • We reviewed 9326 abstracts, with 600 selected for full review and 202 utilized for data extraction. • Key findings show that medical therapy, such as sirolimus, can be used alongside percutaneous treatments or surgery for extensive LMs. • Sclerotherapy achieves partial or complete response in over 90% of patients, particularly effective for macrocystic lesions. • Surgery remains a viable option depending on the size, extent, and location of the malformation. • A multidisciplinary approach is recommended for determining the optimal individualized treatment for each patient. 📈 Conclusion: Evidence supporting best practices for LM management is of moderate quality. Many patients benefit from multi-modal treatment tailored to the extent and type of their LM, emphasizing the need for a multidisciplinary approach. For more details, check out the full article: https://lnkd.in/gENWkhmi #PediatricSurgery #LymphaticMalformations #SystematicReview #EvidenceBasedPractice #APSA #MedicalResearch #Sclerotherapy #Surgery #VascularAnomalies

I'm thrilled to share our PCPLC Pediatric Colorectal and Pelvic Learning Consortium's latest publication in the Journal of Pediatric Surgery! Our study, "Comparison of the PCPLC Database to NSQIP-P: A Patient Matched Comparison of Surgical Complications Following Repair of Anorectal Malformation," highlights a critical advancement in pediatric surgical care. Why is this study important? Anorectal malformations (ARM) are rare and complex, making it challenging to establish best practices. By comparing 30-day outcomes from the PCPLC registry with the NSQIP-P database, we demonstrated a 91% concordance rate, proving the reliability of our data. This means more accurate tracking of complications and better-informed decisions for patient care. Our findings validate the PCPLC as a robust tool for improving surgical outcomes and ensuring high-quality care for children with ARM. This work paves the way for enhanced research, improved protocols, and ultimately, better health outcomes for these young patients. Join us in driving forward the standards of pediatric surgery. Read the full article to discover how we're making a difference! https://lnkd.in/gkwsaRkw #PediatricSurgery #HealthcareInnovation #QualityImprovement #PCPLC #NSQIPP #ResearchImpact #ChildHealth #pedscolorectal

Ophthopedia Update:Congenital Cataracts with Thin Lenses (Leptophakia) in Children: Morphology and Surgical Outcomes: To describe the morphology and postoperative outcomes of pediatric cataracts with thin (leptophakic) lenses. #Ophthalmology #Ophthotwitter #Scicomm

https://lnkd.in/ggvswU5s Article title: Blood conservation protocol based on modified ultrafiltration towards bloodless pediatric surgery   Author(s): L Marzano; PF Ballerini   Journal: Archives of Clinical Hypertension   Journal ISSN: 2640-771X Summary: The authors present a case of a histologically confirmed giant cell arteritis that presented unusually with fever and Horner’s syndrome. The aetiology of the presenting features and the treatment choices are discussed. #GiantCellArteritis #HornerSyndrome #Fever #ArterialBloodPressure #ArterialHypertension #BloodPressureMonitoring #BloodPressureVariability #CardiovascularRisks #CentralBloodPressure #HighBloodPressure #HypertensionDuringPregnancy #HypertensionInChildren #HypertensionInNewborn #HypertensionManagement #HypertensionNeonate #HypertensionNursing #HypertensionNutrition #HypertensionRiskFactors #HypertensionTreatment #Peertechz #PeertechzPublications #HypertensiveCrisis #HypertensiveEmergency #IdiopathicIntracranialHypertension #InducedHypertension #IntracranialHypertension #LowBloodPressure #PersistentPulmonaryHypertension #PortalHypertension #ProtopulmonaryHypertension #PulmonaryHypertension #RenalDisorders #TraumaticIntracranialHypertension

🔖 Treating advanced peripheral arterial occlusive disease (e.g. PAOD IV) poses a significant challenge for clinicians, as conventional treatments quite often fall short at this stage. 👨 A 55-year-old patient who was treated at the Department of Vascular & Endovascular Surgery, EUREGIO Hospital in Nordhorn, Germany. Upon presentation at the outpatient clinic, his condition was notably poor, exhibiting pre-sepsis signs and at the upper left leg amputation site complications were present. 🔻 Previous attempts at multiple stump revisions and various wound treatments yielded unsatisfactory results for both the patient and the medical team. The clinical team tried successively: open wound treatments, vacuum therapy (NPWT), grups therapy, fish skin application, split skin graft, hyperbaric-O2 therapy however nothing succeeded in any form. 👉 The patient ultimately was treated with DEBRICHEM® and just 5 days after a single application, the wound was clean, dry and manageable in a patient's home situation, allowing for the patient to leave the hospital and a better chance at preventing further severe complications. #DEBRICHEM #PAOD #NonHealingWounds #WoundInfection #AdvancedWoundCare

Am I a candidate for EECP? EECP is not for everyone. The MUST-EECP study excluded patients who had a heart attack or bypass surgery in the preceding three months. Anyone with severe heart weakness or congestive heart failure was also omitted from the trial. Because the timing of the compressors requires a stable heart rhythm, anyone with cardiac rhythm abnormalities such as atrial fibrillation or other irregularities was not included. Patients who have very poor circulation of the legs or severe varicose veins may be not tolerated the strong leg compressions that are an integral part of EECP.  Patients aren’t good candidates for EECP if they have left main artery disease, significant aortic insufficiency, an abdominal aortic aneurysm, severe peripheral vascular disease, lower extremity edema, or frequent atrial arrhythmia, have a history of deep vein thrombosis, or are pregnant. #eecp #ecp #eecptreatment #eecptherapy #vamedmedical #eecpmalaysia #eecpindia #eecpmc3 #pskhealth #cardiac +8618223240978

Medial canal fibrosis : •It is the formation of thick, solid fibrous tissue in the medial part of the bony external ear canal, which can be partial or complete. •The most common causes are recurrent infections or inflammation (56%), followed by iatrogenic (37%) and idiopathic (7%) causes [2]. There are two stages of medial canal fibrosis, the wet and the dry. In the wet phase, the symptoms of otorrhea and ear fullness will be present due to inflammation of the ear canal, which subsequently heals with progressive fibrosis and stenosis. In the dry phase, the main symptoms are conductive hearing loss and dry ears. •The management of this disease can be medical or surgical treatment. Medical therapy is a choice for patients in the wet phase while surgery is for patients in the dry phase. #audiology #entsurgeon #worldhealthorganization

How long to wait before considering breast surgery if currently breastfeeding? It is advisable for patients to wait at least six months after breastfeeding before considering breast surgery. This timeframe allows the breast tissues to stabilise and return to a more consistent size and shape, minimising potential complications and optimising surgical outcomes. However, individual circumstances may vary, and it is crucial for patients to consult with Dr Mark Doyle who can assess their specific situation and provide personalised recommendations based on factors such as overall health, hormonal changes, and the individual's postpartum recovery. #breastfeeding #breastsurgery #breastsurgerygoldcoast ………………………………..⁠ ⁠ Any surgical or invasive procedure carries risks and needs an adequate recovery period. One person’s results shown don’t reflect all results. Normal body variation is natural. ⁠ ⁠ If you are interested or have any questions, please contact us on:⁣⁠⁣⁠⁣⁠⁣⁠⁣⁣⁣⁠⁣⁣⁠⁣⁣⁠ • 1300 558 ⁠⁣⁣⁠⁣⁣⁠888 ⁠ • [email protected]⁠ Dr Mark Doyle | MBBS FRACS | MED0001375519